Outcome | Non-NK1RA group | NK1RA group | Risk Difference | P value |
---|---|---|---|---|
(n = 31) | (n = 31) | (95% CI) | ||
CR | ||||
Overall | 29 (93.5%) | 30 (96.8%) | -3.2% (-18.7 to 10.9) | 1.000 |
Acute | 31 (100%) | 31 (100%) | 0% | |
Delayed | 29 (93.5%) | 30 (96.8%) | -3.2% (-18.7 to 10.9) | 1.000 |
CC | ||||
Overall | 29 (93.5%) | 29 (93.5%) | 0% (-16.6 to 16.6) | 1.000 |
Acute | 31 (100%) | 31 (100%) | 0% | |
Delayed | 29 (93.5%) | 29 (93.5%) | 0% (-16.6 to 16.6) | 1.000 |
TC | ||||
Overall | 27 (87.1%) | 26 (83.9%) | 3.2% (-16.6 to 22.9) | 1.000 |
Acute | 31 (100%) | 30 (96.8%) | 3.2% (-8.4 to 16.7) | 1.000 |
Delayed | 27 (87.1%) | 27 (87.1%) | 0% (-19.0 to 19.0) | 1.000 |